Filana Therapeutics, Inc. (FLNA) Tops Q1 EPS by 10c

Filana Therapeutics, Inc. (NASDAQ: FLNA) reported Q1 EPS of ($0.21), $0.10 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Filana Therapeutics, Inc. (FLNA) click here.

You May Also Be Interested In

• Citi upgrades Bath & Body Works to Buy with $25 price target
• Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance